Evidium

Based in San Francisco, United States, Evidium develops a computational medical knowledge platform that utilizes artificial intelligence to provide reliable, traceable, and explanatory clinical insights for healthcare professionals. The company offers enterprise software products, including Quality Insights for clinicians and Probabilistic Forecasting for risk modeling, targeting health insurers, provider networks, and life sciences organizations. Evidium recently secured $22 million in Series A funding to scale its commercial operations and expand its workforce by making strategic hires across clinical science and business development. This financing round was co-led by Health2047 and WGG Partners, with additional equity participation from institutional investors including Interwoven Ventures and Mindset Ventures. The startup maintains strategic ties to the American Medical Association through its venture studio and executive board representation. The healthcare technology company was founded by chief executive officer Carl Bate.